Cell culture solution, method for producing cell culture solution, and cell culture method

A cell culture solution with fibroblast growth factor and ultrafine bubbles addresses the high cost issue by enabling effective cell culture at lower FGF concentrations, improving culture efficiency and reducing expenses.

JP2024159601APending Publication Date: 2024-11-08CANON KK
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
JP2024068301
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-04-28
Filing Date
2024-04-19
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

Existing cell culture methods require high concentrations of expensive growth factors like fibroblast growth factor (FGF) to achieve sufficient culture effects, leading to increased costs.

Method used

A cell culture solution containing fibroblast growth factor (FGF) and ultrafine bubbles (UFB) with a diameter of less than 1.0 μm is used, allowing for effective cell culture at lower FGF concentrations.

Benefits of technology

The solution enables sufficient cell culture even at reduced FGF concentrations, enhancing the culture effect and reducing costs while maintaining cell proliferation and viability.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024159601000001_ABST
    Figure 2024159601000001_ABST
Patent Text Reader

Abstract

To provide a cell culture solution that allows sufficient cell culture even when a fibroblast growth factor as one of growth factors, is used at a lower concentration than conventionally, to provide a method for producing the cell culture solution, and to provide a cell culture method.SOLUTION: The present invention provides a cell culture solution containing a fibroblast growth factor (FGF) and ultrafine bubbles (UFB), a method for producing the cell culture solution, and a cell culture method using the cell culture solution.SELECTED DRAWING: Figure 9
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present disclosure relates to a cell culture medium using a liquid containing ultrafine bubbles (UFB) having a diameter of less than 1.0 μm, in particular a cell culture medium using UFB water and growth factors, a method for producing the cell culture medium, and a cell culture method using the cell culture medium. [Background technology]

[0002] Generally, when culturing animal cells, a culture medium is used in which serum has been added to a basal medium (or culture solution) consisting of amino acids, vitamins, and inorganic salts. Growth factors such as cytokines and hormones may also be added to promote the culture effect. These growth factors are used to reduce the amount of serum used and in culture techniques that use serum-free media, and are essential for promoting cell proliferation (Patent Document 1).

[0003] Furthermore, in recent years, techniques have been developed that utilize the properties of minute bubbles, such as microbubbles with diameters of micrometers and nanobubbles with diameters of nanometers. In particular, the usefulness of ultra-fine bubbles (hereinafter, also referred to as "UFB") with a diameter of less than 1.0 μm has been confirmed in various fields. For example, as described in Patent Document 2, the application of UFB is expected in the field of cells (Patent Document 2). [Prior art documents] [Patent documents]

[0004] [Patent Document 1] Japanese Patent Publication No. 63-192381 [Patent Document 2] Patent Publication No. 2021-73989 Summary of the Invention [Problem to be solved by the invention]

[0005] On the other hand, in order to obtain a sufficient culture promoting effect by adding low molecular weight proteins such as cytokines / hormones, especially growth factors, it is necessary to add them at high concentrations in case they are ineffective. However, the aforementioned growth factors are expensive, and the use of high concentrations increases the culture cost.

[0006] Therefore, there is a need for an efficient culture method in the culture using growth factors. Therefore, an object of the present disclosure is to provide a cell culture medium that enables sufficient cell culture even when fibroblast growth factor, which is a type of growth factor, is used at a lower concentration than in the past. [Means for solving the problem]

[0007] The present disclosure is characterized by a cell culture medium containing fibroblast growth factor (FGF) and ultra-fine bubbles (UFB). Effect of the Invention

[0008] According to the present disclosure, it is possible to provide a cell culture medium that enables sufficient cell culture even when a fibroblast growth factor, which is one of the growth factors, is used at a lower concentration than in the past. [Brief description of the drawings]

[0009] [Figure 1] FIG. 2 is a diagram showing an example of a T-UFB manufacturing apparatus. [Diagram 2] FIG. 1 is a perspective view showing a T-UFB generation unit 1000. [Diagram 3] FIG. 11 is an exploded perspective view of a heating element substrate 1100. [Figure 4] FIG. 2 is a block diagram showing a control configuration in a T-UFB-containing liquid producing apparatus 2000 of the present embodiment. [Diagram 5] 13 is a flowchart showing a process for producing a UFB-containing liquid in a T-UFB-containing liquid producing apparatus 2000 of the present embodiment. [Figure 6] This is an example of particle size distribution measurement of T-UFB. [Figure 7] It is a flowchart of the cell culture treatment before the cell proliferation activity measurement (assay). [Figure 8] It is a flowchart of the cell proliferation activity measurement (assay). [Figure 9] It is a graph showing the relationship between the relative luminescence intensity of ATP and the concentration of growth factor (FGF2) in Example 1 and Comparative Example 1.

Mode for Carrying Out the Invention

[0010] The mode for carrying out the present disclosure will be described in detail with reference to the drawings, but the scope of the present disclosure is not limited to the embodiments described below. Physical property values are values at room temperature (25°C) unless otherwise specified. Details will be described later, and the UFB generated using film boiling is referred to as T-UFB (Thermal-Ultra Fine Bubble).

[0011] <UFB-containing Liquid Production Apparatus and UFB-containing Liquid> Hereinafter, with reference to the drawings, a UFB-containing liquid used to obtain a cell culture solution containing UFB according to an embodiment of the present disclosure, and a UFB-containing liquid production apparatus will be described.

[0012] FIG. 1 is a schematic configuration diagram showing a UFB-containing liquid production apparatus 2000 (hereinafter referred to as a T-UFB-containing liquid production apparatus 2000) to which the present embodiment is applicable and which generates UFB using film boiling. The T-UFB-containing liquid production apparatus 2000 includes a liquid supply unit 600, a gas supply unit 800, an accommodation chamber 900, and a UFB generation unit 1000 (hereinafter referred to as a T-UFB generation unit 1000) that generates UFB using film boiling. In FIG. 1, solid arrows indicate the flow of liquid, and broken arrows indicate the flow of gas.

[0013] The liquid supply unit 600 includes a liquid storage unit 601, two pumps 602 and 603, and a degassing unit 604. The liquid W stored in the liquid storage unit 601 is sent by the pump 602 to a storage chamber 900 capable of storing liquid via the degassing unit 604. A membrane through which only gas can pass is provided inside the degassing unit 604. By reducing the pressure inside the degassing unit 604 by the action of the pump 603, only gas passes through the membrane, and the gas and liquid are separated, and the liquid W moves to the storage chamber 900 while the gas is discharged to the outside. There is a possibility that various gases are dissolved in the liquid stored in the liquid storage unit 601, but by removing the dissolved gas by the degassing unit 604 before sending the liquid to the storage chamber 900, the dissolution efficiency of the gas G described later can be increased.

[0014] The gas supply unit 800 has a cylinder 804 for storing a desired gas G, a valve 806, and an adjustment valve 807, and the gas G is supplied to the storage chamber 900 by adjusting the flow rate. Any gas desired to be contained in the UFB can be selected as the gas G.

[0015] The storage chamber 900 contains the liquid W supplied from the liquid supply unit 600 and the gas G supplied from the gas supply unit 800, and the desired gas G is dissolved in the liquid W. Furthermore, as described below, the liquid W is supplied from the storage chamber 900 to the T-UFB generation unit 1000, the liquid W is impregnated with UFB, and the generated UFB-containing liquid is stored in the storage chamber 900. The temperature sensor 905 detects the temperature of the liquid stored in the storage chamber 900. The liquid level sensor 902 is disposed at a predetermined height in the storage chamber 900 and detects the liquid level of the liquid W. The UFB concentration sensor (concentration detection means) 906 detects the UFB concentration of the liquid W stored in the storage chamber 900. The solubility sensor 907 detects the solubility of the gas G in the liquid W stored in the storage chamber 900. The valve 904 is opened when the liquid W stored in the storage chamber 900 is discharged to an external container via the recovery path 909. The safety valve 908 opens when the internal pressure of the containing chamber 900 rises excessively. Although not shown in the figure, a stirring means may be provided inside the containing chamber 900 to make the temperature of the liquid W and the distribution of the UFB uniform.

[0016] The cooling unit 903 can control the temperature of the liquid W contained in the storage chamber 900, and can cool the liquid W that has become hot. In order to efficiently dissolve the desired gas G, it is preferable that the temperature of the liquid W is as low as possible. In this embodiment, the temperature of the liquid W is adjusted to 10° C. or less using the cooling unit 903 while detecting the temperature of the liquid W with the temperature sensor 905. The configuration of the cooling unit 903 is not particularly limited, but it is possible to adopt, for example, a method using a Peltier element or a method of circulating a liquid cooled by a chiller. In the latter case, a cooling pipe for circulating the cooling liquid may be wound around the outer periphery of the storage chamber 900 as shown in FIG. 1, or the storage chamber 900 may have a hollow structure and the cooling pipe may be arranged in the hollow. In addition, the cooling pipe may be immersed in the liquid W in the storage chamber 900.

[0017] The T-UFB generation unit 1000 is provided with a valve 1003 (blocking means) on the upstream side, and a recovery pump 704 is provided on the downstream side of the T-UFB generation unit 1000. As shown in Fig. 1, the liquid supply section 600, the storage chamber 900, and the UFB generation unit 1000 are connected by piping 700 to form a circulation path B in which the liquid W is circulated by the supply pump 703 and the recovery pump 704.

[0018] In the circulation path B, the liquid W can be circulated regardless of whether the UFB generation unit 1000 is driven. For example, during UFB generation, the liquid W can be circulated at a flow rate that matches the total amount of droplets discharged from the discharge port (1112 in FIG. 3) of the UFB generation unit 1000, and during times other than UFB generation, the liquid W can be circulated at a flow rate that differs from that during UFB generation.

[0019] The position and number of pumps are not limited to those shown in FIG. 1. Furthermore, pumps and valves required for driving each part may be provided in the configuration of each part. However, it is preferable to use a pump with small pulsation and flow rate variation as the pump so as not to impair the generation efficiency of UFB. Furthermore, the recovery path 909 and valve 904 for recovering the liquid W may be provided at other positions in the liquid circulation path, not in the storage chamber 900. Furthermore, the temperature sensor 905, the UFB concentration sensor 906, and the solubility sensor 907 do not necessarily have to be provided at the positions shown in FIG. 1. These sensors may be provided at other positions as long as they are within the circulation path. Furthermore, they may be provided at multiple positions in the circulation path, and an average value may be output.

[0020] It is preferable that components that come into contact with the UFB-containing liquid, such as the piping 700, the supply pump 703, the recovery pump 704, the valve 1003, the storage chamber 900, and the UFB generation unit 1000, are made of a material that is highly corrosion-resistant. For example, fluororesins such as polytetrafluoroethylene (PTFE) and perfluoroalkoxyalkane (PFA), metals such as SUS316L, and other inorganic materials can be suitably used. This makes it possible to suitably generate UFB even when a highly corrosive gas G or liquid W is used.

[0021] FIG. 2 is a perspective view showing the T-UFB generating unit 1000, and FIG. 3 is an exploded perspective view of a heating element substrate 1100 of the T-UFB generating unit 1000. The T-UFB generating unit 1000 generates UFB in the liquid W that is introduced. In this embodiment, an inkjet type liquid ejection head is used as a method for generating UFB. This liquid ejection head is a Thermal-Ultra Fine Bubble (T-UFB) type that generates film boiling at the interface between the heating element 1102 and the liquid. The T-UFB generating unit 1000 includes a plurality of heating element substrates 1100. The heating element substrate 1100 includes a silicon substrate (hereinafter referred to as a Si substrate) 1101 and an ejection port plate 1110. The ejection port plate 1110 has a plurality of ejection ports 1112 arranged therein, and a plurality of heating elements 1102 are arranged on the Si substrate 1101. A plurality of heating element substrates 1100 are supported and arranged on a support member 1300 attached to a T-UFB generating unit housing 1400. Terminals 1103 for connecting to a flexible wiring 1200 are arranged on the Si substrate 1101. Power is supplied to the heating element 1102 via the flexible wiring 1200 and the terminals 1103, and the heating element 1102 generates heat when a voltage pulse is applied. The liquid W is supplied to the heating element 1102 from a supply path 1104a and is collected in a recovery path 1105a. At this time, droplets containing UFB are discharged from a discharge port 1112 by causing the heating element 1102 arranged between the supply path 1104a and the recovery path 1105a to generate heat. In addition, a temperature sensor (temperature detection means) 1107 is formed in an area of ​​the heating element substrate 1100 where the heating element 1102 is not arranged, and reads the temperature of the heating element substrate 1100.

[0022] The UFB-containing liquid was generated by ejecting the liquid W in the form of droplets into the gas from the discharge port 1112. The ejected droplets are collected by the collection unit 1002 shown in Fig. 1. That is, in this embodiment, the liquid W is circulated between the T-UFB generation unit 1000 and the storage chamber 900 via the circulation path B, and the circulation path includes a portion where the liquid W turns into droplets and flies through the gap.

[0023] 4 is a block diagram showing a control configuration of the T-UFB-containing liquid producing apparatus 2000 of this embodiment. The CPU 2001 controls the entire apparatus according to a program stored in the ROM 2002, using the RAM 2003 as a work area. The pump control unit 2004 controls the operation of various pumps including the pumps 602, 603, 703, and 704 included in the circulation path shown in FIG. 1 under the instruction of the CPU 2001. The valve control unit 2005 is configured to be able to control the opening and closing of various valves including the valves 806, 904, and 1003 under the instruction of the CPU 2001. The sensor control unit 2006 controls various sensors including the solubility sensor 907, the liquid level sensor 902, the temperature sensor 905, and the UFB concentration sensor 906 under the instruction of the CPU 2001, and provides the detection values ​​of the various sensors to the CPU 2001.

[0024] Fig. 5 is a flowchart showing the generation process of UFB-containing liquid in the T-UFB-containing liquid manufacturing apparatus 2000 of this embodiment. The generation process of UFB-containing liquid in this embodiment will be described below with reference to the flowchart in Fig. 5. The series of processes shown in Fig. 5 are performed by the CPU 2001 of the T-UFB-containing liquid manufacturing apparatus 2000 expanding the program code stored in the ROM 2002 into the RAM 2003 and executing it. Alternatively, some or all of the functions of the steps in Fig. 5 may be realized by hardware such as an ASIC or electronic circuit. Note that the symbol "S" in the description of each process indicates that it is a step in the flowchart.

[0025] When the generation process of the UFB-containing liquid is started, the CPU 2001 stores a predetermined amount of liquid in the containing chamber 900 in S01. Specifically, the CPU 2001 drives the pumps 602 and 603 while monitoring the detection of the liquid level sensor 902. As a result, the liquid W stored in the liquid supply unit 600 is sent to the containing chamber 900 while being degassed in the degassing unit 604. Then, when the liquid level sensor 902 detects the liquid level, the CPU 2001 stops driving the pumps 602 and 603. As a result, a predetermined amount of liquid W is stored in the containing chamber 900.

[0026] Thereafter, in S02, the CPU 2001 starts temperature control of the liquid W contained in the containing chamber 900. Specifically, while monitoring the temperature detected by the temperature sensor 905, the CPU 2001 drives the cooling unit 903. Then, in S03, when the temperature detected by the temperature sensor 905 becomes 10° C. or lower, the CPU 2001 opens the valve 806 and starts dissolving the gas G.

[0027] Thereafter, in S04, when the solubility sensor 907 detects a predetermined solubility, the CPU 2001 drives the T-UFB generation unit 1000 to generate UFB. As described above, since the T-UFB generation unit 1000 and the storage chamber 900 can circulate through the circulation path B, the UFB concentration increases in proportion to the number of circulations. Then, when the UFB concentration sensor 906 detects a predetermined concentration, the operation of the T-UFB unit 1000 is stopped.

[0028] The temperature control and the gas solubility control may be performed continuously or intermittently while the UFB generation is being performed. Preferably, they are performed continuously. That is, while monitoring the temperature sensor 905 and the solubility sensor 907, the driving of each part can be started and stopped so that the temperature and gas solubility ranges are within a predetermined range. In this way, by setting the temperature range and gas solubility range of the liquid W in which the UFB is generated within a specific range, the UFB generation conditions can be controlled and a more uniform UFB-containing liquid can be generated. Then, in S05, the CPU 2001 ends all driving, opens the valve 904, and collects the UFB-containing liquid, thereby completing the process.

[0029] The T-UFB method allows the production of a UFB-containing solution with a peak diameter of approximately 100 nm and small particle size variation at the desired UFB concentration. The UFB in the UFB-containing solution obtained in this way is more uniform, and the UFB-containing solution can retain bubbles for several months or more.

[0030] As a technique for generating UFB in the UFB generation process, in addition to the above-mentioned T-UFB method, an inkjet method using a piezoelectric element or an electrostatic method may be used. Other UFB generation techniques include a swirling liquid flow type, a static mixer type, a Venturi type, a pressurized dissolution type, a fine hole type, a type using an ultrasonic element, a type using a spray, etc. Alternatively, UFB may be generated in the cell culture solution by injecting the cell culture solution into a production vessel and vibrating the production vessel with the desired gas sealed inside.

[0031] By using the inkjet method, it is possible to produce UFBs at high concentrations from ultrapure water, and in particular, the T-UFB method can produce UFBs at 100 million particles / mL or more, making it suitable for cell culture in the present disclosure.

[0032] It is also preferable to generate UFBs by ejecting the liquid in the form of droplets into the gas, and more preferably to eject the liquid from an inkjet liquid ejection head into the gas, thereby producing a UFB-containing liquid with a higher UFB concentration.

[0033] <Cell culture medium, cell culture medium manufacturing method, and cell culture method> In one embodiment of the present disclosure, the cell culture medium contains fibroblast growth factor (FGF) and ultra-fine bubbles (UFB). Then, the cell culture medium is used to perform cell culture. Hereinafter, the cell culture medium containing UFB is also referred to as a "UFB-containing culture medium."

[0034] 1.Culture cells The cells to which the cell culture method of the present embodiment is applied include adhesive cells, floating cells, spheroids (aggregate cells), etc. Specific examples thereof include human cervical cancer cell lineage cells, nerve cells, hepatocytes, fibroblasts, myoblasts, smooth muscle cells, cardiac muscle cells, skeletal muscle cells, stem cells, mesodermal stem cells, embryonic stem cells, glial cells, mast cells, adipocytes, blood cells, etc. The cells may be primary cells obtained by collecting cells from a living body, cell lines obtained by culturing such cells, frozen cells, etc.

[0035] Other cells that can be used include pluripotent stem cells, multipotent stem cells, unipotent stem cells, etc. "Stem cells" generally have "self-renewal" which allows them to proliferate while maintaining an undifferentiated state, and "pluripotency" which allows them to differentiate into various cell types.

[0036] The species from which the cells are derived is not particularly limited, and examples thereof include humans and non-human mammals. Examples of non-human mammals include rodents such as rats and mice, lagomorphs such as rabbits, ungulates such as pigs and cows, carnivores such as dogs and cats, and primates such as monkeys and chimpanzees.

[0037] 2.Cell culture medium In this embodiment, the cell culture medium contains fibroblast growth factor (FGF) and ultra-fine bubbles (UFB). By using UFB, sufficient cell culture can be performed even when the concentration of FGF is reduced. The reason for this is unclear, but the present inventors speculate as follows.

[0038] The liquid near the surface of the UFB has a negative charge. On the other hand, FGF also has a portion with a positive charge at the end of multiple molecular chains. Therefore, it is possible for FGF to be easily present near the surface of the UFB by electrostatic interaction. In addition, FGF is smaller in size than UFB. Therefore, many FGFs can be attached to one UFB. As a result, the inventors speculate that FGF can be efficiently delivered to cells, and sufficient cell culture could be performed even if the concentration of FGF was reduced.

[0039] (fibroblast growth factor) Fibroblast growth factor (FGF) is a type of growth factor, a low molecular weight protein, which is produced in the body. Growth factors regulate various cellular and physiological processes, and act as intercellular signaling substances by specifically binding to receptor proteins (receptors) on the surface of target cells. There are said to be more than several hundred types of growth factors, but few of them have been elucidated in terms of function and structure. Growth factors can be classified into several families that are structurally and evolutionarily related, and fibroblast growth factors (FGFs) are used in this embodiment. FGFs are growth factors for fibroblasts, and are widely used in cell experiments and as therapeutic agents. About 20 types are known in humans. The fibroblast growth factor is preferably selected from the FGF family consisting of FGF1 to FGF10. Here, the FGF family consisting of FGF1 to FGF10 means FGF1, FGF2, FGF3, FGF4, FGF5, FGF6, FGF7, FGF8, FGF9, and FGF10. FGF1 to 10 are all known to bind to fibroblast growth factor receptors (FGFR). FGF1 is known as acidic FGF (or aFGF), and FGF2 is known as basic FGF (or bFGF). Among these FGFs, FGF2 is particularly preferred. The present inventors speculate that this is because FGF2 is basic and therefore likely to have a positive charge when added to a liquid such as water, making it more likely to interact with UFB.

[0040] FGF2 is an 18 kDa protein consisting of 155 amino acids, but is also produced as 22 kDa, 22.5 kDa, 24 kDa, and 34 kDa high molecular weight (HMW) FGF2 isoforms. In general, the 18 kDa (155 amino acids) low molecular weight (LMW) type is located in the cytoplasm and may be secreted from the cell, while the high molecular weight (HMW) type is known to be transported to the cell nucleus.

[0041] Furthermore, FGF may be one in which the functional groups of the molecule have been altered in order to maintain activity, that is, one whose molecular structure has been altered (denatured FGF).

[0042] (Ultra Fine Bubbles) The gas constituting the UFB contained in the UFB-containing culture solution may include air, hydrogen, nitrogen, oxygen, carbon dioxide, etc., and may also include low molecular weight hydrocarbons such as methane, ethane, propane, butane, pentane, ethylene, propylene, etc. The gas constituting the UFB may be only one type, or may be a combination of two or more types.

[0043] The average particle size of the UFBs contained in the UFB-containing culture solution is preferably 10 nm or more and less than 1000 nm, more preferably 50 nm or more and 500 nm or less, and even more preferably 50 nm or more and 220 nm or less. In the present invention, the average particle size of the UFBs refers to the average value of the number concentration distribution of the diameter of the UFBs.

[0044] The UFB concentration in the UFB-containing culture medium is preferably 1 million cells / mL or more, more preferably 100 million cells / mL or more, and even more preferably 1 billion cells / mL or more.

[0045] If the concentration of UFB in the UFB-containing culture solution is too high, it is expected that UFBs will collide with each other due to Brownian motion of the liquid. Therefore, the upper limit of the UFB concentration in the UFB-containing culture solution is, for example, preferably 120 billion / mL or less at room temperature (25°C), and more preferably 10 billion / mL or less.

[0046] The average particle size of UFB can be measured by, for example, a laser diffraction / scattering method, a nanoparticle tracking analysis method, an electrical resistance method, an AFM (Atomic Force Microscope), observation with a laser microscope, etc. An example of a measuring device using the laser diffraction / scattering method is Shimadzu Corporation's product name: SALD7500nano.

[0047] UFB concentration can be measured using particle trajectory analysis or resonance mass measurement, and particle size distribution as a number concentration can be obtained using quantitative laser diffraction / scattering.

[0048] As an AFM measuring device, for example, MS-NEX (product name) of the high-speed AFM NanoExplorer (registered trademark of Biomolecular Measurement Laboratory Co., Ltd.) of Biomolecular Measurement Laboratory Co., Ltd. can be used. The method of including UFB in the cell culture solution may be a method of directly generating UFB in the cell culture solution, or a method of preparing a UFB-containing solution by the above-mentioned method and dissolving the powdered medium component.

[0049] The cell culture medium of the present disclosure preferably contains a medium, such as Dulbecco's Modified Eagle Medium (hereinafter, DMEM), Iscove's Modified Dulbecco's Medium (hereinafter, IMDM), Hanks' Balanced Salt Solutions (hereinafter, HBSS), Minimun Essential Medium-Eagle, Earle's Salts Base, with Non-Essential Amino Acid (hereinafter, MEM-NEAA), Roswell Park Memorial Institute Medium 1640 (hereinafter, RPMI1640), etc.

[0050] Other examples include StemSure (registered trademark of Fujifilm Wako Pure Chemical Industries, Ltd.), StemFit (registered trademark of Ajinomoto Co., Inc.), and mixtures thereof, which are commercially available as culture media for stem cells.

[0051] The medium may be in the form of a liquid or a powder (solid). In the case of a powdered medium, the powdered medium may be dissolved in a liquid such as ultrapure water to prepare a solution.

[0052] It is preferable to use water to prepare the cell culture solution. As the water, pure water having a resistivity of 1 MΩ·cm or more and less than 15 MΩ·cm may be used, or ultrapure water having a resistivity of 15 MΩ·cm or more and 18.2 MΩ·cm or less may be used. In order to avoid the influence of water on cells, it is preferable to use ultrapure water as the water. In particular, it is preferable to use ultrapure water having a resistivity of 17 MΩ·cm or more and 18.2 MΩ·cm or less. Pure water can be obtained by subjecting water to a method such as reverse osmosis membrane treatment, distillation treatment, or ion exchange treatment. In addition, ultrapure water can be obtained by subjecting water to a method such as ion exchange resin treatment, distillation treatment, Milli-Q (registered trademark) device treatment, reverse osmosis membrane treatment, or a combination of these treatments.

[0053] The UFB-containing culture medium may further contain additives such as serum, serum substitutes, plasma, serum albumin, proteins, growth factors, cytokines, hormones, amino acids, vitamins, antibiotics, inorganic salts (NaCl, KaCl, etc.) and organic salts (sodium lactate, sodium citrate, etc.) as necessary.

[0054] Examples of serum include fetal bovine serum (FBS or fetal calf serum, FCS), calf serum (CF), horse serum, and fetal horse serum. The serum can be added at any concentration, such as 0.1 to 20%, with 5 to 10% being preferred. Note that the cell culture medium of the present disclosure may be a serum-free culture medium to which no serum is added.

[0055] Examples of antibiotics that can be used include penicillin, streptomycin, fungizone, gentamicin, and puromycin.

[0056] It is preferable to sterilize the cell culture solution before use. Methods for sterilizing the cell culture solution include high-temperature treatment (autoclave), gamma rays, UV light, and filtration sterilization. Sterilization of UFB-containing culture solution at 100°C or higher may reduce the UFB, so sterilization is preferably performed at 100°C or lower.

[0057] The aperture of the filter used for filtration sterilization is preferably 100 to 1000 nm for the purpose of filtering out bacteria, and specifically, a filter with an aperture of 440 nm or 220 nm is preferably used.

[0058] 3. Cell culture medium production method In one embodiment of the present disclosure, a method for producing a cell culture medium containing fibroblast growth factor (FGF) and ultra-fine bubbles (UFB) includes a UFB production process for producing the UFB in a liquid, and a mixing process for producing the cell culture medium by mixing a UFB-containing liquid containing the UFB produced in the UFB production process with the fibroblast growth factor.

[0059] In the UFB production step, UFB can be produced using the above-mentioned UFB-containing liquid production device. Then, in the mixing step, the obtained UFB-containing liquid and the above-mentioned FGF are mixed to produce a cell culture solution. Although there is no particular limitation on the method of mixing the UFB-containing liquid and the FGF in the mixing step, it is preferable to mix them in such a way that foaming does not occur in the cell culture solution.

[0060] It is not preferable to produce UFB from a liquid in which FGF has already been mixed using the above-mentioned UFB-containing liquid production apparatus, as this may affect the dispersibility of the FGF. It is also preferable to further include a gas dissolving step of dissolving a gas in a liquid prior to the UFB generating step.

[0061] 4. Cell culture method In one embodiment of the present disclosure, the cell culture method involves culturing cells using a cell culture medium containing the above-mentioned fibroblast growth factor (FGF) and ultra-fine bubbles (UFB).

[0062] Specifically, the cell culture method includes a culture step of culturing cells in a UFB-containing culture medium. In the culture step, the cells are cultured in the UFB-containing culture medium by batch culture, fed-batch culture, continuous culture, perfusion culture, or the like.

[0063] Batch culture is a method of culturing cells without replenishing the UFB-containing culture medium in the culture tank during cell culture.

[0064] Fed-batch culture is a method of culturing cells while replenishing the UFB-containing culture medium in the culture tank during cell culture. Continuous culture is a method of culturing cells while extracting a portion of the UFB-containing culture medium from the culture tank during cell culture and replenishing the UFB-containing culture medium in an amount equivalent to the amount extracted.

[0065] Perfusion culture is a method in which only the liquid is extracted from a culture tank during cell culture, and the culture medium containing UFB is replenished in an amount equivalent to the amount extracted.

[0066] 5.Culture container The incubator may be a flask, a dish, a petri dish, a microwell plate, a microslide, a chamber slide, a tube, a tray, a culture bag, a culture tank, etc., which are used in ordinary cell culture. Examples of the substrate for these incubators include glass, various plastics such as polypropylene and polystyrene, metals such as stainless steel, and combinations thereof.

[0067] The culture step may be adhesion culture or suspension culture. In adhesion culture, a scaffold material such as collagen, gelatin, poly-L-lysine, poly-D-lysine, laminin, a partial structure of laminin, fibronectin, or a mixture thereof (e.g., Matrigel) is coated on the substrate surface of the culture vessel to form a scaffold on the substrate surface. This allows for the adhesion of anchorage-dependent cells to the substrate surface.

[0068] The cell culture density may be any density that can achieve the effect of promoting cell survival and proliferation.

[0069] 6. Cell Culture Conditions Culture conditions such as temperature, dissolved CO2 concentration, dissolved oxygen concentration, and pH can be appropriately set based on techniques conventionally used for culturing cells derived from animal tissues. For example, the culture temperature is preferably 33°C to 39°C, more preferably 36°C to 37°C. The dissolved CO2 concentration is preferably 1% to 10%, more preferably 2% to 5%. The oxygen partial pressure may be, for example, 10% to 22%. EXAMPLES

[0070] The present disclosure will be further described below with reference to examples and comparative examples, but the present disclosure is not limited in any way by the following examples as long as it does not deviate from the gist of the disclosure. "Parts" and "%" used to describe the amounts of components are by weight unless otherwise specified.

[0071] 1. Cell culture treatment before cell proliferation assay The procedure for culturing and treating cells prior to the cell proliferation activity assay is shown below.

[0072] (Preparation of cell culture fluid (growth medium) for cell proliferation) First, a cell culture medium for cell proliferation used for the cell culture treatment prior to the cell proliferation activity measurement (assay) test was prepared by the following method. FBS (serum) was added to liquid DMEM at a concentration of 10%, and antibiotics penicillin and streptomycin were added at a concentration of 1%, to obtain mixture 1. The trade names and manufacturers of the materials used to prepare mixture 1 are as follows: Liquid DMEM (Product name: Dulbecco's modified Eagle's medium (1.0 g / l glucose) (containing L-glutamine and pyruvic acid) (liquid), catalog No. 08456-65, manufactured by Nacalai Tesque) FBS (Product name: Fetal Bovine Serum, Catalog No. 10437-028, manufactured by Gibco) Penicillin and streptomycin (trade name: Penicillin-Streptomycin Mixed Solution, catalogue no. 09367-34, manufactured by Nacalai Tesque)

[0073] This mixed solution 1 was sterilized by filtration using a filter (product name: Stericup Quick Release Durapore, catalog No. S2GVU05RE, manufactured by Merck, representative filter diameter: 220 nm) to prepare a cell culture solution for cell proliferation.

[0074] (Cell culture treatment before cell proliferation activity measurement (assay)) Frozen mouse fibroblast BALB / 3T3 clone A31 cells (hereinafter referred to as A31 cells) were thawed and propagated and passaged in a cell culture medium for cell proliferation for use. The thawing method was performed by shaking in a 37°C water bath.

[0075] Cell proliferation, subculture, and recovery were carried out as follows. (1) Add 5 mL of DPBS(-) (phosphate buffer containing no divalent cations) to each dish containing A31 cells, and shake the dish to wash the cell surface. (2) Remove the DPBS(-) used to wash the cell surface by aspiration, and add 2 mL of DPBS(-) containing 0.25% Trypsin-EDTA to the dish. Place the dish in a 37°C CO2 incubator for 5 minutes and confirm that the cells have detached from the bottom of the dish and started to float. (3) Add 5 mL of the cell culture medium (growth medium) for cell proliferation described above to this dish to stop the action of trypsin, and immediately pipette to make a single-cell suspension. Transfer the suspension to a multipurpose refrigerated centrifuge. (4) Using a multipurpose refrigerated centrifuge, centrifuge at room temperature with a centrifugal force of 180×G ("G" stands for gravitational acceleration) for 5 minutes, then aspirate and discard as little of the supernatant as possible. (5) The centrifuged cells are suspended in a precise amount of the cell culture medium (growth medium) for cell growth described above. (6) Take a sample of 20 μL using a pipette or the like, and count the number of cells. The number of cells can be counted by accurately diluting the sample with 0.25% trypan blue and counting the cells using a hemocytometer or by using an image assessment device. (7) Dilute the cells taking into consideration the cell number and viability, seed them on a new dish, and culture them in a 37°C CO2 incubator.

[0076] The above steps (1) to (7) were repeated, and when the cells had sufficiently proliferated to the required cell number, the cells were detached and used in the cell proliferation activity measurement (assay) described below. A flow chart of the cell culture treatment before the above-mentioned cell proliferation activity measurement (assay) test is shown in Figure 7. The trade names and manufacturers of the materials and equipment used in the cell culture treatment before the assay test are as follows: DPBS(-) (Product name: Dulbecco's Phosphate Buffered Saline, Catalog No. 14190250, Thermo Fisher Scientific) Trypsin-EDTA (Product name: 2.5 g / l-trypsin / 1 mmol / l-EDTA solution, containing phenol red, Catalog No. 32777-44, manufactured by Nacalai Tesque) CO2 incubator (product name: SCA-165DRS, manufactured by Astec) ·Multi-purpose refrigerated centrifuge (product name: CAX-571, manufactured by TOMY) 96 well white plate (Product name: 96 Well White / Clear Bottom Plate, TC Surface, Catalog No. 165306, Thermo Fisher Scientific)

[0077] 2. Cell proliferation activity assay The procedure for the cell proliferation activity assay is shown below.

[0078] (Preparation of cell culture medium for assay) First, a cell culture medium for assay was prepared by the following method.

[0079] First, 90% of ultrapure water for 1 L of the basal culture solution was slowly stirred with a magnetic stirrer, while 1 L of powdered DMEM and 3.7 g / L of NaHCO3 were added. Then, further ultrapure water was added to reach the specified concentration to prepare 1 L of basal culture solution containing ultrapure water.

[0080] The ultrapure water used here had a resistivity of 17 MΩ·cm or more and had been treated by a combination of ion exchange resin treatment, distillation treatment, Milli-Q (registered trademark) device treatment, and reverse osmosis membrane treatment.

[0081] To the obtained basal culture medium, 10% FBS (serum), 1% penicillin and streptomycin (antibiotics), and FGF2 (fibroblast growth factor) were added to the concentrations described below to obtain a mixture 2. The trade names and manufacturers of the materials used to prepare this mixture 2 are as follows. Powdered DMEM (product name: DMEM, powder, low glucose, pyruvate, catalog number 31600034, manufactured by Thermo Fisher Scientific) FBS (Product name: Fetal Bovine Serum, Catalog No. 10437-028, manufactured by Gibco) Penicillin and streptomycin (trade name: Penicillin-Streptomycin Mixed Solution, catalogue no. 09367-34, manufactured by Nacalai Tesque)

[0082] This mixed solution 2 was sterilized by filtration using a filter (product name: Stericup Quick Release Durapore, catalog No. S2GVU05RE, manufactured by Merck, representative filter diameter 220 nm) to prepare a cell culture medium for assay used in Comparative Example 1.

[0083] In addition, the cell culture medium for assay used in Example 1 was prepared in the same manner as the cell culture medium for assay used in Comparative Example 1, except that a UFB-containing solution produced by the T-UFB method was used instead of ultrapure water. In addition, the cell culture medium for assay used in Comparative Example 2 was prepared in the same manner as the cell culture medium for assay used in Comparative Example 1, except that a hepatocyte growth factor (HGF, model number: 294-HG-005 / CF, manufactured by R&D Systems), which is one of the growth factors described below, was used instead of FGF2. In addition, the cell culture medium for assay used in Comparative Example 3 was prepared in the same manner as the cell culture medium for assay used in Example 1, except that HGF was used instead of FGF2.

[0084] The UFB-containing liquid produced by the T-UFB method and used in the cell culture liquid for assay in Example 1 and Comparative Example 3 was prepared as follows.

[0085] In the T-UFB-containing liquid manufacturing apparatus 2000 shown in FIG. 1, the liquid supply unit 600 contained ultrapure water used in the preparation of the cell culture liquid for assay used in Comparative Example 1 as the liquid W, and the gas supply unit 800 contained oxygen as the gas G. Then, the T-UFB-containing liquid manufacturing apparatus 2000 was operated to prepare a UFB-containing liquid manufactured by the T-UFB method. The encapsulated gas of the UFB in the obtained UFB-containing liquid was oxygen. When the obtained UFB-containing liquid was measured using Shimadzu Corporation's SALD (registered trademark) 7500 nano (SALD is a registered trademark of Shimadzu Corporation), the concentration of UFB in the UFB-containing liquid was 600 million / mL, and the average particle size of the UFB was 92 nm. In addition, the concentration of UFB in the cell culture liquid for assay and the average particle size of the UFB were the same as those of the UFB-containing liquid.

[0086] As described above, the UFB-containing solution produced by the T-UFB method is a UFB with small particles and small variation. Therefore, the UFB contained in the UFB-containing solution produced by the T-UFB method and the UFB-containing culture solution produced using this UFB-containing solution can pass through the filter during filtration sterilization without being trapped by the filter. Therefore, the UFB-containing solution produced by the T-UFB method and the UFB-containing culture solution produced using this UFB-containing solution are characterized by low loss of UFB during filtration sterilization. Figure 6 shows an example of the particle size distribution of the UFB-containing solution produced by the T-UFB method. Shimadzu Corporation's SALD (registered trademark) 7500 nano (SALD is a registered trademark of Shimadzu Corporation) was used for the measurement.

[0087] The filter used has a typical aperture of 220 nm, which means that bacteria on the order of a few microns cannot pass through, but UFB can pass through. It can also be seen that the average UFB number concentration is at least smaller than the filter aperture.

[0088] (About cell proliferation activity measurement (assay)) Using the cell culture medium for assay used in Example 1 and the cell culture medium for assay used in Comparative Examples 1 to 3, cell proliferation activity measurement (assay) was carried out as follows.

[0089] Example 1 For the cell culture medium for assay used in the above-mentioned Example 1, FGF2 (model number: 233-FB-010 / CF, manufactured by R&D System) which is a fibroblast growth factor was used, and the amount of FGF2 added was adjusted so that the FGF2 concentrations were 0 ng / mL, 0.01 ng / mL, 0.03 ng / mL, 0.1 ng / mL, 0.3 ng / mL, 1 ng / mL, 3 ng / mL, 10 ng / mL, 30 ng / mL, and 100 ng / mL, to prepare cell culture medium for assay (also referred to as assay medium) with different concentrations of FGF2.

[0090] 50 μL of cell culture medium containing different concentrations of FGF2 was added to a 96-well white plate and equilibrated in a CO2 incubator for 1 hour.

[0091] Then, the cells harvested during the cell culture treatment prior to the cell proliferation activity assay were suspended in cell culture medium for assay on a 96-well white plate, and seeded onto the equilibrated plate at 2,000 cells / well / 100 μL, followed by treatment with the test substance.

[0092] Comparative Example 1 The test substance treatment was carried out in the same manner as in Example 1, except that the cell culture medium for assay used in the above-mentioned Comparative Example 1 was used instead of the cell culture medium for assay used in the above-mentioned Example 1.

[0093] Comparative Example 2 The test substance treatment was carried out in the same manner as in Example 1, except that the cell culture medium for assay used in the above-mentioned Comparative Example 2 (culture medium not containing UFB) was used instead of the cell culture medium for assay used in the above-mentioned Example 1.

[0094] Comparative Example 3 The test substance treatment was carried out in the same manner as in Example 1, except that the cell culture medium for assay used in the above-mentioned Comparative Example 3 (UFB-containing culture medium) was used instead of the cell culture medium for assay used in the above-mentioned Example 1.

[0095] (Evaluation method) After 72 hours of culture in the cell culture medium for each assay in Example 1 and Comparative Examples 1 to 3, the ATP (adenosine triphosphate) assay was used to measure the ATP relative luminescence intensity and evaluate the cell proliferation and FGF2 activity. Specifically, a foam cell viability assay (product name: CellTiter-Glo 2.0 Cell Viability Assay, manufactured by Promega) was used as a reagent, and the luminescence intensity of luminescence generated by binding of ATP to the luminescent substrate in the reagent was measured using a microplate reader (product name: Spark, manufactured by Tecan). The higher the luminescence intensity, the greater the amount of ATP, and generally the greater the number of live cells.

[0096] A flow chart of the cell proliferation activity measurement (assay) is shown in FIG.

[0097] FIG. 9 shows a graph showing the relationship between the relative ATP luminescence intensity as an index of cell activity and the concentration of growth factor (FGF2), with the ATP relative luminescence intensity on the ordinate and the FGF2 concentration on the abscissa. In both the cell culture medium of Example 1 (UFB-containing culture medium) and the cell culture medium of Comparative Example 1 (culture medium not containing UFB) used as a comparison, ATP luminescence increased with increasing FGF2 concentration. When comparing the cell culture medium of Example 1 and Comparative Example 1 at each FGF concentration, when the FGF2 concentration was 0.1 ng / mL or more, the cell culture medium of Example 1 (UFB-containing culture medium) showed an increase in ATP relative luminescence intensity compared to the cell culture medium of Comparative Example 1 (culture medium not containing UFB). From the above results, it is considered that the activity of FGF2, which is a growth factor, was enhanced by including UFB in the cell culture medium.

[0098] Thus, UFB was found to improve activity intensity, especially in areas with high FGF2 concentrations. Considering that FGF2 has a short half-life, it was speculated that this was due to the effect of extending the half-life, which lengthened the duration of action, resulting in an increase in ATP luminescence intensity. In addition, it is thought that UFB inhibits the aggregation of FGF2 itself, increasing its dispersibility and making it easier for it to act on cells. It is also possible that the UFB-containing solution acts on the cells themselves.

[0099] Furthermore, in both the cell culture medium of Comparative Example 3 (UFB-containing culture medium) and the cell culture medium of Comparative Example 2 (UFB-free culture medium), ATP luminescence increased with increasing HGF concentration. However, when comparing the cell culture medium of Comparative Example 3 and Comparative Example 2 at each HGF concentration, no significant difference was observed in the ATP relative luminescence intensity. In other words, in the case of HGF, unlike FGF, the phenomenon of HGF activity being enhanced by the presence of UFB was not observed.

[0100] From this experiment, it is believed that the following effects are obtained. When UFB and FGF coexist, it is thought that UFB suppresses the inactivation of FGF and assists the effect of FGF on the FGF receptor. Possible cell behaviors include cell proliferation, suppression of cell death, and cell activation.

[0101] In other words, the use of a UFB-containing culture medium has the effect of enhancing the effect of growth factors or reducing the amount of growth factors added for the same culture time.

[0102] It is also expected that ATP production in cells will increase, and that ATP will activate cell migration. In addition, it is expected that ATP will have an effect on cell proliferation, survival, differentiation, development, and adhesion.

[0103] <<Other embodiments>> The present disclosure includes configurations typified by the following example cell culture medium and example cell culture method.

[0104] <Configuration 1> A cell culture medium containing fibroblast growth factor (FGF) and ultra-fine bubbles (UFB). <Configuration 2> 2. The cell culture medium according to claim 1, wherein the fibroblast growth factor is selected from the FGF family consisting of FGF1 to FGF10. <Configuration 3> 3. The cell culture medium of claim 2, wherein the fibroblast growth factor comprises FGF2. <Configuration 4> 4. The cell culture medium according to any one of claims 1 to 3, wherein the concentration of the UFB is 1 million cells / mL or more. <Component 5> 5. The cell culture medium according to any one of claims 1 to 4, wherein the concentration of the UFB is 100 million cells / mL or more. <Component 6> 6. The cell culture medium according to any one of claims 1 to 5, wherein the average particle size of the UFB is 50 nm or more and 220 nm or less. <Component 7> A method for producing a cell culture solution containing fibroblast growth factor (FGF) and ultra-fine bubbles (UFB), comprising: a UFB generation step of generating the UFB in a liquid; a mixing step of mixing a UFB-containing solution containing the UFB produced in the UFB production step with the fibroblast growth factor to produce the cell culture solution; A method for producing a cell culture medium, comprising the steps of: <Component 8> 8. The method for producing a cell culture medium according to claim 7, further comprising a gas dissolving step of dissolving a gas in the liquid prior to the UFB generating step. <Component 9> 9. The method for producing a cell culture medium according to configuration 7 or 8, wherein in the UFB generating step, the liquid is caused to fly in the form of droplets into a gas to generate the UFB. <Component 10> 10. The method for producing a cell culture medium according to configuration 9, wherein the liquid is ejected from an inkjet liquid ejection head to fly in the gas. <Component 11> A cell culture method using the cell culture medium according to any one of claims 1 to 6. [Explanation of symbols]

[0105] 600 Liquid supply section 601 Liquid storage section 602 Pump 1 603 Pump 2 604 Deaeration section 800 Gas supply section 804 Gas storage cylinders 806 Valve 807 Adjustment valve 900 Containment Room 903 Cooling section 904 Valve 905 Temperature Sensor 906 UFB concentration sensor (concentration detection means) 907 Solubility Sensor 909 Recovery Route 1000 T-UFB generating unit 1100 Multiple heating element substrate 1101 Si substrate 1102 Multiple heating elements 1103 Terminal 1104a Supply route 1105a Recovery route 1107 Temperature Sensor 1110 Outlet plate 1112 Multiple outlets 1200 Flexible Wiring 1300 Support member 1400 T-UFB generating unit housing 2000 T-UFB containing liquid production equipment

Claims

1. A cell culture medium containing fibroblast growth factor (FGF) and ultrafine bubbles (UFB).

2. The cell culture medium according to claim 1 , wherein the fibroblast growth factor is selected from the FGF family consisting of FGF1 to FGF10.

3. The cell culture medium according to claim 2 , wherein the fibroblast growth factor comprises FGF2.

4. The cell culture medium according to claim 1 , wherein the concentration of the UFB is 1 million cells / mL or more.

5. The cell culture medium according to claim 1 , wherein the concentration of the UFB is 100 million cells / mL or more.

6. The cell culture medium according to claim 1, characterized in that the average particle size of the UFB is 50 nm or more and 220 nm or less.

7. A method for producing a cell culture solution containing fibroblast growth factor (FGF) and ultra-fine bubbles (UFB), comprising: A UFB generation step of generating the UFB in a liquid; a mixing step of mixing a UFB-containing solution containing the UFB produced in the UFB production step with the fibroblast growth factor to produce the cell culture solution; A method for producing a cell culture medium, comprising the steps of:

8. The method for producing a cell culture medium according to claim 7 , further comprising a gas dissolving step of dissolving a gas in the liquid prior to the UFB generating step.

9. The method for producing a cell culture medium according to claim 7 , wherein in the UFB generating step, the UFB is generated by causing the liquid to fly in the form of droplets into a gas.

10. The method for producing a cell culture solution according to claim 9 , wherein the liquid is ejected from an inkjet liquid ejection head to fly in the gas.

11. A cell culture method using the cell culture medium according to any one of claims 1 to 6.

Citation Information

Patent Citations

  • Cell capable of subcultivation in serum-free culture medium and method for obtaining said cell

    JP1988192381A

  • Cell culture method, method for producing culture solution, culture solution and culture device

    JP2021073989A